This press release contains forward looking statements that involve a number of risks and uncertainties, the outcome could affect materially and / or adversely affect the actual future results article . In particular, the risks and uncertainties that could affect the development of XYOTAX and pixantrone, risks with preclinical and clinical developments in the biopharmaceutical industry in general and with XYOTAX and pixantrone in particular are associated also include, without limitation, to the potential failure of XYOTAX and pixantrone to prove safe and effective for the treatment of non-small cell lung cancer and non-Hodgkin’s lymphoma, included determinations by regulatory, patent and administrative governmental authorities, competitive factors, technological developments, costs of developing, producing and selling XYOTAX and pixantrone, and the risk factors or described from time to time in the Company’s filings with the Securities and Exchange Commission, including, without limitation, the Company most recent filings on forms 10 – K, 8-K and 10-Q. Required required by Italian law, CTI is under no obligation update or alter any forward-looking statements, whether. As a result of new information, future events or otherwise.
This study will not have a big influence on the incidence of HIV / AIDS in the United States or Europe, where heterosexual transmission of HIV is low areas like sub-Saharan Africa and parts of Asia, compared to, Bailey said. To child. It are other health benefits circumcision, including better hygiene, fewer urinary tract infections, and a lower risk of cervical cancer in the partner countries of circumcised men. . Read More